At IVISYS we gladly share information about our company with the public. Here you find our latest news.
IVISYS AB (‘IVISYS’) has today published the interim report for the period January to March 2019. Below is a summary of the report. Press releaseIVISYS
Press Release IVISYS AB 556998-4981 27February 2019 IVISYS AB (“IVISYS”, “The Company”) has carried out a directed issue of 1,883,450 shares and has therebyreceived
Press release IVISYS AB 556998-4981 25 February 2019 IVISYS AB (‘IVISYS’) has today published its interim report for the period January to December 2018. Below
Press Release IVISYS AB 556998-4981 06 February 2019 As of February 4, 2018, IVISYS has calculated the value of the orders outstanding, including the
Press Release IVISYS AB 556998-4981 18December 2018 IVISYS (’IVISYS’) has recieved an initial order combined with a LOI worth more than 5,0 MSEK. IVISYS
Press Release IVISYS AB 556998-4981 22 January 2019 IVISYS (’IVISYS’) has receivedarepeat order for one Implant Inspector to Nobel Biocare, similar to 2 already
Press Release IVISYS AB 556998-4981 28 November 2018 IVISYS (’IVISYS’) has received an order from Gnosjö Automatsvarvning for upgrading an existing IVISYS system to increase
Press release IVISYS AB 556998-4981 26 November 2018 IVISYS AB (‘IVISYS’) has today published the interim report for the period January to September 2018. Below
Press Release IVISYS AB 556998-4981 November 26, 2018 IVISYS (‘IVISYS’) has a target of a turnover of at least SEK 20.0 million in 2019 with
Press release IVISYS AB 556998-4981 23 November 2018 IVISYS (’IVISYS’) has passed the 1,0 MSEK milestone in recurrent income from service agreements with existing clients.
